Pancreas-visceral fat CT value ratio and serrated pancreatic contour are strong predictors of postoperative pancreatic fistula after pancreaticojejunostomy.


Journal

BMC surgery
ISSN: 1471-2482
Titre abrégé: BMC Surg
Pays: England
ID NLM: 100968567

Informations de publication

Date de publication:
11 Jun 2020
Historique:
received: 25 11 2019
accepted: 31 05 2020
entrez: 13 6 2020
pubmed: 13 6 2020
medline: 15 12 2020
Statut: epublish

Résumé

Our aim is to elucidate the true preoperative risk factors for postoperative pancreatic fistula (POPF) after pancreaticoduodenectomy (PD), making it possible to select POPF high-risk patients preoperatively regardless of intraoperative pancreatic consistency judged by the surgeon's hand. Among the 298 patients who underwent PD with pancreaticojejunostomy from 2007 to 2016, 262 patients had preoperative CT configurations that could be precisely evaluated. Risk factor analyses were conducted using various perioperative factors, including preoperative CT findings, such as CT values of the pancreas, pancreas-visceral fat CT value ratio and pancreatic outer contour. Pancreatic outer contour was further divided into smooth- (smooth interlobular) and serrated-type contours (feathery, irregular interlobular) by preoperative CT. In terms of the incidence of POPF, among the 262 patients, POPF grade B/C was found in 27 (10.3%): grade B in 23 (8.8%) and grade C in 4 (1.5%). According to multivariate analysis, a high pancreas-visceral fat CT value ratio (p = 0.002), serrated-type contour (p = 0.02) and no history of chemoradiotherapy (p = 0.019) were identified as independent risk factors for POPF grade B/C. Even in patients with soft pancreas, the incidence of POPF grade B/C was 0% (0/57) in patients with a pancreas-visceral fat CT value ratio of less than - 0.4 and smooth-type contour, whereas the incidence was markedly high (45.0%, 9/20) in patients with a pancreas-visceral fat CT value ratio of - 0.4 or greater and serrated-type contour, indicating that patients with soft pancreas should be categorized into POPF high-risk and low-risk groups according to preoperative CT scan results. The pancreas-visceral fat CT value ratio and serrated-type pancreas are useful markers to preoperatively identify true POPF high-risk groups in patients undergoing PD, regardless of the pancreatic texture judged intraoperatively.

Sections du résumé

BACKGROUND BACKGROUND
Our aim is to elucidate the true preoperative risk factors for postoperative pancreatic fistula (POPF) after pancreaticoduodenectomy (PD), making it possible to select POPF high-risk patients preoperatively regardless of intraoperative pancreatic consistency judged by the surgeon's hand.
METHODS METHODS
Among the 298 patients who underwent PD with pancreaticojejunostomy from 2007 to 2016, 262 patients had preoperative CT configurations that could be precisely evaluated. Risk factor analyses were conducted using various perioperative factors, including preoperative CT findings, such as CT values of the pancreas, pancreas-visceral fat CT value ratio and pancreatic outer contour. Pancreatic outer contour was further divided into smooth- (smooth interlobular) and serrated-type contours (feathery, irregular interlobular) by preoperative CT.
RESULTS RESULTS
In terms of the incidence of POPF, among the 262 patients, POPF grade B/C was found in 27 (10.3%): grade B in 23 (8.8%) and grade C in 4 (1.5%). According to multivariate analysis, a high pancreas-visceral fat CT value ratio (p = 0.002), serrated-type contour (p = 0.02) and no history of chemoradiotherapy (p = 0.019) were identified as independent risk factors for POPF grade B/C. Even in patients with soft pancreas, the incidence of POPF grade B/C was 0% (0/57) in patients with a pancreas-visceral fat CT value ratio of less than - 0.4 and smooth-type contour, whereas the incidence was markedly high (45.0%, 9/20) in patients with a pancreas-visceral fat CT value ratio of - 0.4 or greater and serrated-type contour, indicating that patients with soft pancreas should be categorized into POPF high-risk and low-risk groups according to preoperative CT scan results.
CONCLUSIONS CONCLUSIONS
The pancreas-visceral fat CT value ratio and serrated-type pancreas are useful markers to preoperatively identify true POPF high-risk groups in patients undergoing PD, regardless of the pancreatic texture judged intraoperatively.

Identifiants

pubmed: 32527310
doi: 10.1186/s12893-020-00785-w
pii: 10.1186/s12893-020-00785-w
pmc: PMC7291550
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

129

Références

Ann Surg. 2014 Apr;259(4):773-80
pubmed: 24253151
J Hepatobiliary Pancreat Sci. 2017 Dec;24(12):649-656
pubmed: 29032609
J Am Coll Surg. 2010 Jan;210(1):54-9
pubmed: 20123332
Surgery. 2017 Mar;161(3):584-591
pubmed: 28040257
Dig Surg. 2016;33(3):169-76
pubmed: 26854944
J Hepatobiliary Pancreat Sci. 2012 Mar;19(2):116-24
pubmed: 22076668
Br J Surg. 2012 Aug;99(8):1076-82
pubmed: 22556164
World J Surg. 2016 Aug;40(8):1959-68
pubmed: 27071610
Surgery. 2010 Jul;148(1):15-23
pubmed: 20138325
J Gastrointest Surg. 2013 Oct;17(10):1744-51
pubmed: 23975030
Surgery. 2011 Sep;150(3):547-56
pubmed: 21621236
Ann Surg. 1995 Oct;222(4):580-8; discussion 588-92
pubmed: 7574936
J Gastrointest Surg. 2006 Nov;10(9):1280-90; discussion 1290
pubmed: 17114014
J Gastrointest Surg. 2017 May;21(5):846-854
pubmed: 28101719
J Gastrointest Surg. 2014 Jun;18(6):1108-15
pubmed: 24733259
Ann Surg. 2006 Jul;244(1):10-5
pubmed: 16794383
J Gastroenterol Hepatol. 2013 Sep;28(9):1507-14
pubmed: 23577962
Ann Surg. 2007 Dec;246(6):1058-64
pubmed: 18043111
Surgery. 2003 Nov;134(5):766-71
pubmed: 14639354
Microsc Microanal. 2013 Jun;19(3):553-8
pubmed: 23628379
Am J Surg. 1994 Oct;168(4):295-8
pubmed: 7524375
J Hepatobiliary Pancreat Sci. 2011 Jul;18(4):601-8
pubmed: 21491103
Ann Surg. 2010 May;251(5):932-6
pubmed: 20395858
J Gastrointest Surg. 2007 Dec;11(12):1699-703
pubmed: 17786530
Ann Surg. 2006 Dec;244(6):931-7; discussion 937-9
pubmed: 17122618
World J Gastrointest Surg. 2010 Aug 27;2(8):260-4
pubmed: 21160885
Surgery. 2015 Jun;157(6):1088-98
pubmed: 25799468
Pancreatology. 2018 Jan;18(1):73-78
pubmed: 29248543
Pancreatology. 2017 Sep - Oct;17(5):814-821
pubmed: 28705553
J Gastrointest Surg. 2016 Dec;20(12):1975-1985
pubmed: 27730398
J Gastrointest Surg. 2004 Dec;8(8):951-9
pubmed: 15585382
World J Gastroenterol. 2005 Apr 28;11(16):2456-61
pubmed: 15832417
Gastroenterology. 1997 Sep;113(3):983-94
pubmed: 9287993
Diabetologia. 2016 Aug;59(8):1753-9
pubmed: 27179658
J Am Coll Surg. 2013 Jan;216(1):1-14
pubmed: 23122535
World J Surg. 2013 Jun;37(6):1405-18
pubmed: 23494109
Surgery. 2010 Apr;147(4):503-15
pubmed: 20018335

Auteurs

Tomoki Kusafuka (T)

Department of Hepatobiliary Pancreatic and Transplant Surgery, Mie University Graduate School of Medicine, 2-174 Edobashi, Tsu, Mie, 514-8507, Japan.

Hiroyuki Kato (H)

Department of Hepatobiliary Pancreatic and Transplant Surgery, Mie University Graduate School of Medicine, 2-174 Edobashi, Tsu, Mie, 514-8507, Japan. katohiroyuki510719@gmail.com.

Yusuke Iizawa (Y)

Department of Hepatobiliary Pancreatic and Transplant Surgery, Mie University Graduate School of Medicine, 2-174 Edobashi, Tsu, Mie, 514-8507, Japan.

Daisuke Noguchi (D)

Department of Hepatobiliary Pancreatic and Transplant Surgery, Mie University Graduate School of Medicine, 2-174 Edobashi, Tsu, Mie, 514-8507, Japan.

Kazuyuki Gyoten (K)

Department of Hepatobiliary Pancreatic and Transplant Surgery, Mie University Graduate School of Medicine, 2-174 Edobashi, Tsu, Mie, 514-8507, Japan.

Aoi Hayasaki (A)

Department of Hepatobiliary Pancreatic and Transplant Surgery, Mie University Graduate School of Medicine, 2-174 Edobashi, Tsu, Mie, 514-8507, Japan.

Takehiro Fujii (T)

Department of Hepatobiliary Pancreatic and Transplant Surgery, Mie University Graduate School of Medicine, 2-174 Edobashi, Tsu, Mie, 514-8507, Japan.

Yasuhiro Murata (Y)

Department of Hepatobiliary Pancreatic and Transplant Surgery, Mie University Graduate School of Medicine, 2-174 Edobashi, Tsu, Mie, 514-8507, Japan.

Akihiro Tanemura (A)

Department of Hepatobiliary Pancreatic and Transplant Surgery, Mie University Graduate School of Medicine, 2-174 Edobashi, Tsu, Mie, 514-8507, Japan.

Naohisa Kuriyama (N)

Department of Hepatobiliary Pancreatic and Transplant Surgery, Mie University Graduate School of Medicine, 2-174 Edobashi, Tsu, Mie, 514-8507, Japan.

Yoshinori Azumi (Y)

Department of Hepatobiliary Pancreatic and Transplant Surgery, Mie University Graduate School of Medicine, 2-174 Edobashi, Tsu, Mie, 514-8507, Japan.

Masashi Kishiwada (M)

Department of Hepatobiliary Pancreatic and Transplant Surgery, Mie University Graduate School of Medicine, 2-174 Edobashi, Tsu, Mie, 514-8507, Japan.

Shugo Mizuno (S)

Department of Hepatobiliary Pancreatic and Transplant Surgery, Mie University Graduate School of Medicine, 2-174 Edobashi, Tsu, Mie, 514-8507, Japan.

Masanobu Usui (M)

Department of Hepatobiliary Pancreatic and Transplant Surgery, Mie University Graduate School of Medicine, 2-174 Edobashi, Tsu, Mie, 514-8507, Japan.

Hiroyuki Sakurai (H)

Department of Hepatobiliary Pancreatic and Transplant Surgery, Mie University Graduate School of Medicine, 2-174 Edobashi, Tsu, Mie, 514-8507, Japan.

Shuji Isaji (S)

Department of Hepatobiliary Pancreatic and Transplant Surgery, Mie University Graduate School of Medicine, 2-174 Edobashi, Tsu, Mie, 514-8507, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH